Objectives: Several cases of unusual thrombotic events with thrombocytopenia were
reported in several countries, in association with AstraZeneca's COVID-19 vaccine. The …

Summary The coronavirus disease 2019 (Covid‐19) pandemic has had devastating effects
on public health worldwide, but the deployment of vaccines for Covid‐19 protection has …

Background: As of 8 April 2021, a total of 2.9 million people have died with or from the
coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021 …

Introduction The World Health Organization declared the coronavirus disease 2019 (COVID-
19) pandemic on March 11, 2020. Two vaccine types were developed using two different …

A 27-year-old fit and well man presented with intermittent headaches associated with eye
floaters and vomiting. His symptoms started 48 hours after having the first dose of ChADOx1 …

OBJECTIVES: Vaccine-induced immune thrombotic thrombocytopenia is an unexpected
consequence of the coronavirus disease 2019 pandemic era. We reviewed the …

Background There are concerns about a link between the ChAdOx1 nCoV-19 and Ad26.
COV2. S vaccines against COVID-19 and cerebral venous thrombosis (CVT) and other …

Background and purpose Population‐based studies suggest that severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) vaccines may trigger immune‐mediated thrombotic …

Background: Thrombosis with thrombocytopenia syndrome (TTS) is a potentially life-
threatening condition associated with adenoviral-vectored COVID-19 vaccination. It presents …

The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is
recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia …